It should be no shock that the pharmaceutical industry is not all that happy with seeing cannabis legalized. Like tobacco companies, a win for cannabis means a loss for them. So any chance either industry gets to block the passing of legal cannabis, they will.
One Senator is not happy with what she sees as the pharmaceutical industry halting legalization of cannabis.
Per Forbes
A prominent Democratic U.S. senator is slamming pharmaceutical companies for opposing marijuana legalization.
“To them it’s competition for chronic pain, and that’s outrageous because we don’t have the crisis in people who take marijuana for chronic pain having overdose issues,” Sen. Kirsten Gillibrand of New York said. “It’s not the same thing. It’s not as highly addictive as opioids are.”
“On the federal level, we really need to say it is a legal drug you can access if you need it,” she said.
Gillibrand, in an appearance on Good Day New York on Friday morning, was responding to a question about whether marijuana is a “gateway drug” that leads people to try more dangerous substances.
